Director
Genmab
Hillsborough, New Jersey, United States
Fulya Akpinar Singh is quantitative systems pharmacology (QSP) modeler at Genmab. She completed her undergraduate degree in Chemical Engineering Department at Middle East Technical University in Turkey. After graduation, she joined Prof. John Yin’s research group for graduate studies in Chemical and Biological Engineering Department at University of Wisconsin-Madison. In her Ph.D. research she studied the interactions between infectious and defective interfering particles in virus cultures experimentally and built mathematical models that capture these interactions.
In 2014 she joined Chemical and Synthetic Development at Bristol Myers Squibb (BMS), where she contributed to the chemical process development for active pharmaceutical ingredients. In 2018 she moved to Quantitative Clinical Pharmacology group at BMS, where she developed quantitative systems pharmacology (QSP) models and mechanistic PKPD models to support fibrosis programs at BMS. In 2021 she joined QSP group in Clinical Pharmacology department at Genmab to lead QSP modeling projects to support preclinical and early clinical immune-oncology programs.
Disclosure(s): No financial relationships to disclose
Wednesday, November 13, 2024
10:45 AM – 12:15 PM MST
Validating QSP Models with Finesse: Elevating Performance through Biologically Anchored Precision
Wednesday, November 13, 2024
11:20 AM – 11:35 AM MST
